scholarly journals Successful pregnancy and delivery following surgical treatment of postmyomectomy uterocutaneous fistula

2019 ◽  
Vol 12 (12) ◽  
pp. e231594
Author(s):  
Mert Yesiladali ◽  
Erdinc Saridogan ◽  
Ertan Saridogan
Keyword(s):  
Uterine Wall ◽  
Reproductive Age ◽  
Fistula Tract ◽  
In Vitro Fertilisation ◽  
Women Of Reproductive Age ◽  
Successful Pregnancy ◽  
Wall Defect ◽  
Pregnancy And Delivery ◽  
Fertilisation Treatment

Uterocutaneous fistula is an extremely rare clinical condition that may be caused by postoperative or postpartum complications, such as infection or inflammation. Although fibroids and myomectomy are common clinical entities among women of reproductive age, there are very few postmyomectomy uterocutaneous fistula cases in the literature. This article presents the first reported case of a succesful pregnancy and live birth following treatment of a postmyomectomy uterocutaneous fistula. After laparoscopic adhesiolysis, a minilaparotomy was performed to excise the fistula tract completely from both the abdominal wall and the uterus. The uterine wall defect was repaired in multiple layers. The patient had a good recovery after surgery, and the uterocutaneous fistula resolved completely. Due to obliteration of both tubal ostia, the patient was referred for in vitro fertilisation treatment. She conceived after the third frozen embryo transfer procedure and gave birth to a 4.4 kg baby at full term by caesarean section.

scholarly journals Men report good mental health 20 to 23 years after in vitro fertilisation treatment

2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Gunilla Sydsjö ◽  
Josefin Vikström ◽  
Marie Bladh ◽  
Barbara Jablonowska ◽  
Agneta Skoog Svanberg
Keyword(s):  
Mental Health ◽  
In Vitro Fertilisation ◽  
Good Mental Health ◽  
Fertilisation Treatment

Successful pregnancy and delivery after in vitro fertilization and embryo transfer in a patient with primary hypopituitarism

2000 ◽  
Vol 73 (5) ◽  
pp. 1057-1058 ◽  
Author(s):  
Nobuhiko Suganuma ◽  
Madoka Furuhashi ◽  
Tomoko Ando ◽  
Yoshimasa Asada ◽  
Osamu Mori ◽  
...  
Keyword(s):  
In Vitro Fertilization ◽  
Embryo Transfer ◽  
Successful Pregnancy ◽  
Vitro Fertilization ◽  
Pregnancy And Delivery

Successful pregnancy following antenatal closure of uterine wall defect

2000 ◽  
Vol 68 (3) ◽  
pp. 261-262 ◽  
Author(s):  
T Fujii ◽  
S Kozuma ◽  
N Unno ◽  
Y Kuwabara ◽  
Y Taketani
Keyword(s):  
Uterine Wall ◽  
Successful Pregnancy ◽  
Wall Defect

Progesterone elevation on the day of oocyte retrieval and live birth rate after in vitro fertilisation treatment

2021 ◽  
pp. 1-5
Author(s):  
Maria Angeles Roque Fernandez ◽  
Cristina Alvarez Lleo ◽  
Esteban Gonzalez Mirasol ◽  
Maria Resta Serra ◽  
Carmen Garcia Garrido ◽  
...  
Keyword(s):  
Live Birth ◽  
Birth Rate ◽  
Live Birth Rate ◽  
Oocyte Retrieval ◽  
In Vitro Fertilisation ◽  
Fertilisation Treatment

scholarly journals Long-acting reversible contraception by effervescent microneedle patch

2019 ◽  
Vol 5 (11) ◽  
pp. eaaw8145 ◽  
Author(s):  
Wei Li ◽  
Jie Tang ◽  
Richard N. Terry ◽  
Song Li ◽  
Aurelie Brunie ◽  
...  
Keyword(s):  
Biodegradable Polymer ◽  
Glycolic Acid ◽  
Interstitial Fluid ◽  
Threshold Level ◽  
Reproductive Age ◽  
Women Of Reproductive Age ◽  
Human Participants ◽  
Microneedle Patch ◽  
Long Acting

To increase access to long-acting contraception, we developed a reversible contraceptive microneedle patch that is simple-to-administer, slowly releases contraceptive hormone (levonorgestrel) for >1 month, and generates no biohazardous sharps waste. After manually pressing the patch to skin for 1 min, microneedles rapidly separate from the patch within the skin due to effervescence triggered by contact with skin’s interstitial fluid, as demonstrated in rats and human participants. Long-acting contraception is achieved by formulating microneedles with a biodegradable polymer [poly(lactic-co-glycolic) acid] that slowly releases levonorgestrel for ~1 month in vitro. In rats, the patch maintained levonorgestrel concentration above the human contraceptive threshold level for >1 month, and a placebo microneedle patch was well-tolerated in human participants. Women of reproductive age in three continents demonstrated interest in and preference for long-acting contraception by microneedle patch. These studies indicate that an effervescent microneedle patch could facilitate greater access to long-acting contraception.

The effect of endometrioma on ovarian reserve

2017 ◽  
Vol 86 (3) ◽  
pp. 237
Author(s):  
Małgorzata Agnieszka Szczepańska ◽  
Paweł P. Jagodziński ◽  
Ewa Wender‑Ożegowska
Keyword(s):  
Ovarian Reserve ◽  
Antral Follicle ◽  
Antral Follicle Count ◽  
Reproductive Age ◽  
In Vitro Fertilisation ◽  
Current State ◽  
Ovarian Endometrioma ◽  
State Of Research ◽  
Ovarian Endometriomas

An ovarian endometrioma is a very common form of endometriosis in women of reproductive age. This review presents the current state of research on ovarian reserve in women with ovarian endometriomas. Endometrioma can negatively affect ovarian markers: the anti‑Müllerian hormone (AMH), antral follicle count (AFC) and in vitro fertilisation (IVF) results. Decisions on the surgical treatment of endometrial cysts should be carefully thought through, especially in women who have not given birth.

Sign in / Sign up

Export Citation Format

Share Document